Ligand Pharmaceuticals (LGND) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Ligand Pharmaceuticals

    NASDAQ: LGND · Real-Time Price · USD
    180.99
    0.87 (0.48%)
    At close: Oct 03, 2025, 3:59 PM
    180.99
    0.00%
    After-hours: Oct 03, 2025, 04:38 PM EDT

    Ligand Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 72.31M 22.95M 45.01M 19.52M
    Short-Term Investments
    		 183.86M 147.35M 166.86M 321.59M
    Long-Term Investments
    		 10.91M 48.32M 3M n/a
    Other Long-Term Assets
    		 202.53M 5.92M 14.22M 23.25M
    Receivables
    		 42.45M 39.31M 35.04M 91.65M
    Inventory
    		 14.11M 23.97M 13.29M 27.33M
    Other Current Assets
    		 16.9M 2.66M 2.27M 4.67M
    Total Current Assets
    		 331.56M 237.43M 263.6M 464.75M
    Property-Plant & Equipment
    		 24.81M 25.06M 15.01M 32.75M
    Goodwill & Intangibles
    		 371.9M 470.27M 458.31M 745.11M
    Total Long-Term Assets
    		 610.22M 549.79M 499.07M 836.63M
    Total Assets
    		 941.77M 787.22M 762.67M 1.3B
    Account Payables
    		 5.23M 2.43M 5.31M 8.4M
    Deferred Revenue
    		 1.9M 1.22M 355K 654K
    Short-Term Debt
    		 1.29M 410K 76.69M 1.41M
    Other Current Liabilities
    		 -4.49M 7.63M 9.54M 17.38M
    Total Current Liabilities
    		 37.11M 16.78M 98.81M 41.66M
    Long-Term Debt
    		 n/a n/a n/a 320.72M
    Other Long-Term Liabilities
    		 35.88M 30.7M 25.38M 80.94M
    Total Long-Term Liabilities
    		 74.22M 69.52M 66.37M 434.77M
    Total Liabilities
    		 111.33M 86.3M 165.18M 479.75M
    Total Debt
    		 7.11M 6.17M 87.75M 324.39M
    Book Value
    		 830.44M 700.91M 597.49M 821.63M
    Book Value Per Share
    		 45.40 40.52 35.42 49.41
    Common Stock
    		 20K 18K 17K 17K
    Retained Earnings
    		 498.98M 503.02M 450.86M 449.09M
    Comprehensive Income
    		 -5.94M -817K -984K -917K
    Shareholders Equity
    		 830.44M 700.91M 597.49M 821.63M
    Total Investments
    		 194.77M 195.68M 169.86M 321.59M

    Add to Watchlist